Author Archives: Ariel Acentares
Lion Biotechnologies, Inc. [NASDAQ: LBIO]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. Oklahoma City, OK (April 18, 2017) – On April 14, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Lion Biotechnologies, Inc. (NASDAQ: LBIO). The complaint… Read More »
U.S. Physical Therapy, Inc. [NYSE: USPH]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. Oklahoma City, OK (April 17, 2017) – On March 31, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against U.S. Physical Therapy, Inc. (NYSE:… Read More »
St. Jude Medical Played Down Defibrillator Failures for Years, F.D.A. Says
The medical device maker St. Jude Medical played down the failure of some batteries in its defibrillators, shipping them for years before recalling the devices last fall, according to a warning letter the Food and Drug Administration issued this week. The company, acquired by Abbott Laboratories in January, also failed to tell its own… Read More »
U.S. Concrete, Inc. [NASDAQ: USCR]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Concrete, Inc. Oklahoma City, OK (March 29, 2017) – On March 28, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of Texas against U.S. Concrete, Inc. (NASDAQ: USCR). The complaint… Read More »
Federman & Sherwood initiates Litigation Against Samsung Electronics America, Inc. and Samsung Electronics Co., Ltd.
Federman & Sherwood initiated litigation against Samsung Electronics America, Inc. and Samsung Electronics Co., Ltd. on January 13, 2017 on behalf of any and all consumers who have a Samsung home washing machines which have an inherently dangerous defect or suffer catastrophic failure during a given machine’s normal usage. Click here to see if… Read More »
Molycorp, Inc. [NYSE: MCP] – Settlement Notice
To: All persons and/or entities who purchased common stock in Molycorp, Inc. [NYSE: MCP] during the period from February 21, 2012 through October 15, 2013, inclusive, and were damaged thereby; a settlement has been announced in the securities litigation known as In re Molycorp, Inc. Securities Litigation , Civil Action No. 13-Civ-5697 (PAC) ,… Read More »
MARD, Inc. f/k/a/ KIOR, Inc. – Settlement Notice
To: All persons and/or entities who purchased common stock in MARD, INC. f/k/a KIOR, INC. (“KIOR”) during the period from June 24, 2011 to March 17, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Carlton, et al., v. Cannon, et al., Case No. 4:15-cv-00012 (S.D. Tex.),… Read More »
UPDATED: KaloBios Pharmaceuticals, Inc. – Settlement Notice
To: All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District… Read More »
The Multiple Stages of Securities Litigation
What is the number one question we are asked by investors who contact our firm when a new securities case is filed? Why do securities class actions take so long to reach a settlement or reach some other type of resolution? Therefore, we decided to write this article to explain the lengthy process each… Read More »
Securities Fraud Class Action Lawsuits
Investors in the stock market should know the purpose of a securities class action based upon fraud allegations, the underlying purpose for filing this type of litigation, and the rules governing such litigation. Typical securities fraud class actions involve “alleged” misrepresentation during a specific period of time regarding a company’s operations, financial performance or… Read More »